Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Panic Disorder clinical trials
7 of 26 indexed Panic Disorder trials are currently recruiting.
26 US clinical trials · 7 currently recruiting
Panic Disorder is the subject of 26 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 6 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is Georgetown University, running 3 of these trials.
The research picture
Panic Disorder has 26 registered US clinical trials, 7 of them open to new participants right now, about 27% of the total.
- 7
- recruiting participants now
- 27%
- of trials open to enrollment
- 6
- in Phase 3–4 (later-stage)
- 3
- top sponsor: Georgetown University
Active & Recent Trials
26 total, page 1 of 1
CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
University of Texas at Austin
NCT05467683
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
University of Minnesota
NCT05117255
Respiratory Training in the Treatment of Transdiagnostic Pathological Anxiety
University of Texas at Austin
NCT05427708
Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD
Baylor College of Medicine
NCT07024758
Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4
University of Michigan
NCT06563310
Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method
Georgetown University
NCT07028216
Mindful Self-Compassion for Anxiety Disorders and Depression
Georgetown University
NCT05671419
Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals
Massachusetts General Hospital
NCT01075672
Evaluation of Family-Based Behavioral Treatments for Youth With Anxiety and Obsessive-Compulsive Disorder
Baylor College of Medicine
NCT05967468
Evaluating the Effects of Stress in Pregnancy
Emory University
NCT00525226
Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment
Mclean Hospital
NCT02305537
Trial to Compare Time to Response in the Symptoms of Anxiety to Concomitant Treatment With Niravam™ and an SSRI or SNRI to Treatment With an SSRI or SNRI Alone in Subjects With Generalized Anxiety Disorder or Panic Disorder
UCB Pharma
NCT00266409
Telephone-Based Care Management Program for Individuals With Anxiety Disorders
University of Pittsburgh
NCT00158327
Pragmatic Collaborative Care for Cardiac Inpatients With Depression or Anxiety
Massachusetts General Hospital
NCT03118752
Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder
Boston University Charles River Campus
NCT00790868
Transdiagnostic Psychotherapy for Veterans With Mood and Anxiety Disorders
VA Office of Research and Development
NCT01947647
Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors With [18F]SPA-RQ
National Institute of Mental Health (NIMH)
NCT00088738
A Study of Risperidone Monotherapy in Bipolar Anxiety
University of South Florida
NCT00167479
Interactive Computer Treatment for Panic Disorder
Florida State University
NCT00063375
Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD)
VA Palo Alto Health Care System
NCT01172652
Effect of Mindfulness Meditation on Physiological Response to Unpredictable Stimuli
Georgetown University
NCT03206437
Efficacy and Mechanisms of Psychosocial Treatments for Panic Disorder
Southern Methodist University
NCT04366011
A 10-Week, Open-Label, Flexible Dose Adaptive Study Evaluating the Efficacy of Vortioxetine in Subjects With Panic Disorder
Siyan Clinical Corporation
NCT02395510
Effectiveness of Cognitive Behavioral Therapy With Panic Control Treatment for Adolescents With Panic Disorder
Boston University
NCT00705380
Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Panic Disorder With Comorbid Major Depression
New York State Psychiatric Institute
NCT00521352
Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks
Lindner Center of HOPE
NCT00279617
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 3 |
| Phase 3 | 2 |
| Phase 4 | 4 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Panic Disorder Trial Landscape
26 indexed Panic Disorder studies · 7 recruiting (27%).
Phase mix: 6 late (III/IV) vs 5 early (I/II).
Top sponsor: Georgetown University (3 trials), 9 others listed. 26 shown below, recruiting first.
How to read this condition's trial landscape
That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation, eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Panic Disorder?
PlainTrial tracks 26 US clinical trials for Panic Disorder, of which 7 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Panic Disorder?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.